News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR Logo
Flower shape and new treatments for myeloma

30/05/13

ICR scientists find a genetic process that determines a flower's shape could also underlie the development of blood cancer.
ICR Logo
A new model for genetic testing in cancer patients

20/05/13

An ICR research programme that will lay the foundations for anyone with cancer to have access to genetic testing has been launched with £2.7 million funding from the Wellcome Trust.
ICR Logo
High-tech scans monitor activity of new drug treatments

15/05/13

Monitoring lactate within tumours using high-tech scans could tell doctors whether or not cancer drugs are working, new research reveals.
ICR Logo
Statement about BRCA genetic research and testing

14/05/13

Statement from the ICR about BRCA genetic research and testing, in the light of the announcement by Angelina Jolie that she has had a double mastectomy to reduce her BRCA1-associated risk of developing breast cancer.
ICR Logo
Large study identifies nine new genomic regions linked to testicular cancer

13/05/13

A study from the ICR involving over 2,000 men has identified nine new regions of the genome associated with testicular cancer.
ICR Logo
Timing of Hodgkin lymphoma radiotherapy to women’s first period critical for breast cancer risk

10/05/13

ICR scientists find radiotherapy near a woman's first period increases breast cancer risk, but pregnancy doesn't increase danger.
The network and interchanges of the London Underground resemble the robust signalling networks of cells
Mapping cancer’s networks

06/05/13

Building up a London Underground-style map of signalling pathways is pinpointing cancer’s weak points
ICR Logo
Researchers identify indicator for drug-resistant head and neck cancers

02/05/13

Scientists have uncovered a secret to why many tumours develop resistance to a class of targeted drug treatments.
ICR Logo
New DNA blood test could increase access to Herceptin

01/05/13

ICR scientists believe a new blood test for women with breast cancer could identify more women who will benefit from the targeted treatment Herceptin without the need for uncomfortable biopsies.
ICR Logo
A double-pronged attack on testicular seminoma

26/04/13

Giving patients a single dose of chemotherapy alongside radiotherapy could improve outcomes for patients with a type of testicular cancer, a new study by The Institute of Cancer Research, London, suggests.
ICR Logo
New Alliance to bring lung cancer trials to population of six million

24/04/13

Leading research institutions and hospitals across London today (Thursday, 25 April) unite to transform the care of lung cancer with plans to invite patients over a population of six million into a pioneering new programme of clinical trials.
ICR Logo
Scientists track down prostate cancer risk to key ageing gene

08/04/13

Researchers have taken a step further in understanding prostate cancer genetics by fine-mapping an area of a chromosome associated with prostate cancer risk.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.